Skip to main content

Table 2 Cox proportional hazards models for progression-free survival following primary androgen deprivation therapy

From: Predictors of survival outcomes in native sub Saharan black men newly diagnosed with metastatic prostate cancer

Variables

Univariate

Multivariate

HR

95% CI

p

HR

95% CI

p

Age

1.01

0.96-1.06

0.706

   

Urban residence

1.44

0.59-3.48

0.421

   

LUTS

2.15

0.70-6.57

0.181

   

aNSAID use

3.80

1.43-10.10

0.007

3.40

0.74-15.66

0.117

Anaemia

1.89

0.77-4.64

0.162

   

Pretreatment PSA

1.00

0.99-1.01

0.913

   

PSA decline

   < 90%

1.00 (Reference)

   

   ≥ 90%

0.36

0.13-1.10

0.063

   

aPSA nadir

  ≤ 4 ng/mL

1.00 (Reference)

   

  > 4 ng/mL

3.86

1.49-10.04

0.006

2.85

1.06-7.67

0.038

Biopsy Gleason score

 6

1.00 (Reference)

   

 7

0.82

0.35-1.91

0.648

   

 8-10

1.26

0.56-2.80

0.579

   
  1. asignificant at univariate analysis and carried onward to multivariate analysis
Back to article page

BMC Urology

ISSN: 1471-2490

Contact us